Sotera Health (SHC) Stock Forecast, Price & News

6 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Sotera Health in the last twelve months. There are currently 3 hold ratings and 3 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" SHC shares.
View SHC analyst ratings or view top-rated stocks.

6 Wall Street research analysts have issued twelve-month price objectives for Sotera Health's stock. Their SHC share price forecasts range from $8.00 to $25.00. On average, they expect the company's stock price to reach $16.50 in the next twelve months. This suggests a possible upside of 8.6% from the stock's current price.
View analysts price targets for SHC or view top-rated stocks among Wall Street analysts.

Sotera Health's stock was trading at $8.33 at the beginning of 2023. Since then, SHC stock has increased by 82.5% and is now trading at $15.20.
View the best growth stocks for 2023 here.

The company is scheduled to release its next quarterly earnings announcement on Thursday, August 3rd 2023.
View our SHC earnings forecast.

Sotera Health (NASDAQ:SHC) issued its quarterly earnings data on Wednesday, November, 10th. The company reported $0.21 earnings per share for the quarter, topping analysts' consensus estimates of $0.19 by $0.02. The business had revenue of $226.16 million for the quarter, compared to analysts' expectations of $222.55 million. Sotera Health had a negative net margin of 26.47% and a positive trailing twelve-month return on equity of 46.84%.

Sotera Health updated its FY 2023 earnings guidance on Wednesday, May, 3rd. The company provided earnings per share (EPS) guidance of $0.78-$0.86 for the period, compared to the consensus EPS estimate of $0.80. The company issued revenue guidance of $1.05 billion-$1.09 billion, compared to the consensus revenue estimate of $1.07 billion.

(SHC) raised $1 billion in an IPO on Friday, November 20th 2020. The company issued 46,600,000 shares at a price of $20.00-$23.00 per share. J.P. Morgan, Credit Suisse, Goldman Sachs, Jefferies, Barclays, Citigroup and RBC Capital Markets served as the underwriters for the IPO and BNP Paribas, Keybanc Capital Markets, Citizens Capital Markets and ING were co-managers.

Sotera Health trades on the NASDAQ under the ticker symbol "SHC."

Sotera Health's stock is owned by a number of institutional and retail investors. Top institutional shareholders include BlackRock Inc. (3.46%), ArrowMark Colorado Holdings LLC (1.69%), Prudential Financial Inc. (1.25%), Boston Partners (1.07%), State Street Corp (0.98%) and Hawk Ridge Capital Management LP (0.65%). Insiders that own company stock include Matthew J Klaben, Michael B Jr Petras, Michael P Rutz and Pincus & Co Warburg.
View institutional ownership trends.

Shares of SHC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of SHC stock can currently be purchased for approximately $15.20.

Sotera Health (NASDAQ:SHC) has a market capitalization of $4.29 billion and generates $1.00 billion in revenue each year. The company earns $-233,570,000.00 in net income (profit) each year or ($0.93) on an earnings per share basis.

The company employs 3,000 workers across the globe.

Sotera Health's mailing address is 9100 SOUTH HILLS BLVD SUITE 300, BROADVIEW HEIGHTS OH, 44147. The official website for the company is www.soterahealth.com. The company can be reached via phone at 440-262-1410 or via email at ir@soterahealth.com.